XTX Topco’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $549K | Buy |
150,901
+104,890
| +228% | +$382K | 0.02% | 1023 |
|
|
2025
Q1 | $88.3K | Buy |
+46,011
| New | +$88.3K | ﹤0.01% | 1895 |
|
|
2024
Q4 | – | Sell |
-44,267
| Closed | -$58.4K | – | 2230 |
|
|
2024
Q3 | $58.4K | Buy |
+44,267
| New | +$58.4K | ﹤0.01% | 1669 |
|
|
2024
Q1 | – | Sell |
-99,645
| Closed | -$124K | – | 1790 |
|
|
2023
Q4 | $124K | Sell |
99,645
-38,861
| -28% | -$48.2K | 0.03% | 1086 |
|
|
2023
Q3 | $158K | Sell |
138,506
-200,861
| -59% | -$229K | 0.03% | 1092 |
|
|
2023
Q2 | $311K | Buy |
+339,367
| New | +$311K | 0.06% | 692 |
|
|
2022
Q2 | – | Sell |
-102,392
| Closed | -$74K | – | 823 |
|
|
2022
Q1 | $74K | Buy |
102,392
+75,635
| +283% | +$54.7K | 0.03% | 552 |
|
|
2021
Q4 | $60K | Buy |
+26,757
| New | +$60K | 0.03% | 544 |
|
|
2021
Q3 | – | Sell |
-20,589
| Closed | -$78K | – | 664 |
|
|
2021
Q2 | $78K | Buy |
+20,589
| New | +$78K | 0.03% | 687 |
|